Gene · 3276
Papers2,987
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,987
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PRMT1 promotes radiotherapy resistance in glioma stem cells by inhibiting ferroptosis. | Jpn J Radiol | 2025 | 39254902 | PubTator, text mining | PubMed |
| Keep calm and reboot - how cells restart transcription after DNA damage and DNA repair. | FEBS Lett | 2025 | 38991979 | PubTator, text mining | PubMed |
| Pathogenesis of cardiovascular diseases: effects of mitochondrial CF6 on endothelial cell function. | Mol Cell Biochem | 2025 | 38985252 | PubTator, text mining | PubMed |
| Looping forward: exploring R-loop processing and therapeutic potential. | FEBS Lett | 2025 | 38844597 | PubTator, text mining | PubMed |
| Repression of PRMT activities sensitize homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatment. | bioRxiv | 2025 | 38826355 | PubTator, text mining | PubMed |
| Targeting the PRMT1-cGAS-STING signaling pathway to enhance the anti-tumor therapeutic efficacy. | J Cancer Biol | 2024 | 40018367 | PubTator, text mining | PubMed |
Molecular Characterization and Potential Inhibitors Prediction of Protein Arginine Methyltransferase-2 in Carcinoma: An Insight from Molecular Docking, ADMET Profiling and Molecular Dynamics Simulation Studies. | Euroasian J Hepatogastroenterol | 2024 | 39802857 | PubTator, text mining | PubMed |
| A Network and Pathway Analysis of Genes Associated With Atrial Fibrillation. | Cardiovasc Ther | 2024 | 39742001 | PubTator, text mining | PubMed |
| Prmt1-mediated histone H4R3me2a methylation regulates the proliferation, migration and invasion of laryngeal cancer cells by affecting the expression level of NCOA5. | Front Oncol | 2024 | 39741976 | PubTator, text mining | PubMed |
| PRMT1 alleviates isoprenaline-induced myocardial hypertrophy by methylating SRSF1. | Acta Biochim Biophys Sin (Shanghai) | 2024 | 39659162 | PubTator, text mining | PubMed |
| Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application. | Signal Transduct Target Ther | 2024 | 39627201 | PubTator, text mining | PubMed |
| PRMT1-mediated methylation of ME2 promotes hepatocellular carcinoma growth by inhibiting ubiquitination. | Cell Death Dis | 2024 | 39528487 | PubTator, text mining | PubMed |
| Oligomerization of protein arginine methyltransferase 1 and its functional impact on substrate arginine methylation. | J Biol Chem | 2024 | 39491649 | PubTator, text mining | PubMed |
| Methylarginine targeting chimeras for lysosomal degradation of intracellular proteins. | Nat Chem Biol | 2024 | 39414979 | PubTator, text mining | PubMed |
| Post-Translational Modifications of RNA-Modifying Proteins in Cellular Dynamics and Disease Progression. | Adv Sci (Weinh) | 2024 | 39377984 | PubTator, text mining | PubMed |
| PRMT1-mediated arginine methylation promotes YAP activation and hepatocellular carcinoma proliferation. | FEBS Open Bio | 2024 | 39367565 | PubTator, text mining | PubMed |
| Overview of PRMT1 modulators: Inhibitors and degraders. | Eur J Med Chem | 2024 | 39316844 | PubTator, text mining | PubMed |
| PRMT1 inhibition perturbs RNA metabolism and induces DNA damage in clear cell renal cell carcinoma. | Nat Commun | 2024 | 39300069 | PubTator, text mining | PubMed |
| P4HB regulates the TGFβ/SMAD3 signaling pathway through PRMT1 to participate in high glucose-induced epithelial-mesenchymal transition and fibrosis of renal tubular epithelial cells. | BMC Nephrol | 2024 | 39251943 | PubTator, text mining | PubMed |
| Structure, Function, and Activity of Small Molecule and Peptide Inhibitors of Protein Arginine Methyltransferase 1. | J Med Chem | 2024 | 39250434 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3276/papers?page=9